FL
Filana Therapeutics, Inc.
FLNA · NASDAQ
$0.77 -9.08% (-$0.08)
1M -16.40%
Market Cap $43.0M
P/E Ratio -
Div. Yield -
ROE 99.85%
Bulios Fair Price
$1.08
39.8% upside
Current Price
$0.77
Undervalued Fair Value Overvalued
According to Bulios Fair Price, FLNA is currently undervalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
1/9Valuation
100 /100
Cheap P/B 0.63x
PEG N/A
P/E N/A
Growth
100 /100
Growing Book val. growth 117.55%
FCF growth N/A
EPS growth N/A
Profitability
-
N/A Op. margin N/A
Gross margin N/A
FCF margin N/A
Quality
0 /100
Poor ROA 71.89%
ROIC 120.10%
Asset turnover 0.00x
Debt
100 /100
Low Current ratio 2.19x
Debt/Equity 0.00x
Debt/Assets N/A
Stability
19 /100
Unstable Profitable years 0
Beta -0.70x
EPS volatility 138.33%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about FLNA
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Richard Jon Barry
Employees
19
Headquarters
Austin
Upcoming events
29 OCT
Earnings
Upcoming earnings report